Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Dominari Holdings - 45 Year Stock Price History | DOMH

Historical daily share price chart and data for Dominari Holdings since 1980 adjusted for splits and dividends. The latest closing stock price for Dominari Holdings as of May 21, 2025 is 4.74.
  • The all-time high Dominari Holdings stock closing price was 1000000.00 on May 28, 1986.
  • The Dominari Holdings 52-week high stock price is 13.58, which is 186.5% above the current share price.
  • The Dominari Holdings 52-week low stock price is 0.83, which is 82.5% below the current share price.
  • The average Dominari Holdings stock price for the last 52 weeks is 2.91.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Dominari Holdings Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 4.6769 1.0455 12.4927 0.9898 4.7400 401.06%
2024 1.9143 2.4505 3.0175 0.8625 0.9460 -61.99%
2023 2.8165 3.3250 4.2763 1.7778 2.4889 -21.04%
2022 5.9336 10.1254 10.1254 2.9502 3.1520 -67.13%
2021 15.9627 14.1344 38.3910 9.3952 9.5896 -32.80%
2020 13.3838 22.8712 52.6038 7.9870 14.2700 -33.83%
2019 37.7026 45.3765 57.4623 17.1534 21.5643 -46.35%
2018 67.4584 86.1935 125.5430 35.6007 40.1929 -54.04%
2017 85.0317 63.7078 244.8410 56.8382 87.4432 34.62%
2016 112.6864 144.7810 191.7510 54.3388 64.9575 -62.59%
2015 668.1378 1281.6700 1341.0000 166.0240 173.6190 -86.45%
2014 2984.9568 10324.4000 10324.4000 964.3370 1281.6700 -86.60%
2013 9954.8490 8089.9400 25752.0000 5067.3400 9565.0400 18.08%
2012 16671.1648 28956.2000 34175.4000 7701.8800 8100.6200 -70.83%
2011 71992.1968 180383.0000 232599.0000 27769.5000 27769.5000 -83.52%
2010 289721.0952 282442.0000 436717.0000 124963.0000 168516.0000 -37.72%
2009 284266.6463 118649.0000 531655.0000 59336.5000 270574.0000 147.83%
2008 188802.6518 284815.0000 306176.0000 47469.2000 109179.0000 -58.56%
2007 471709.0478 503173.0000 674063.0000 263454.0000 263454.0000 -51.10%
2006 484622.5498 790362.0000 842578.0000 284815.0000 538799.0000 -34.20%
2005 554704.4343 806976.0000 1000000.0000 284815.0000 818844.0000 6.15%
2004 926339.6667 1000000.0000 1000000.0000 640834.0000 771374.0000 -22.86%
2003 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2002 999457.0079 1000000.0000 1000000.0000 866313.0000 1000000.0000 0.00%
2001 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
2000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1999 999447.4960 1000000.0000 1000000.0000 956789.0000 1000000.0000 0.00%
1998 981737.2262 1000000.0000 1000000.0000 786208.0000 1000000.0000 0.00%
1997 994499.7211 1000000.0000 1000000.0000 845545.0000 1000000.0000 0.00%
1996 1000000.0000 1000000.0000 1000000.0000 1000000.0000 1000000.0000 0.00%
1995 815254.2511 563697.0000 1000000.0000 504360.0000 1000000.0000 68.53%
1994 773502.7565 919716.0000 949384.0000 563697.0000 593365.0000 -33.33%
1993 799668.4449 979052.0000 1000000.0000 534028.0000 890047.0000 11.11%
1992 889246.6883 608199.0000 1000000.0000 608199.0000 801043.0000 28.57%
1991 720868.9798 192844.0000 1000000.0000 163175.0000 623033.0000 250.00%
1990 458691.4444 586007.0000 637867.0000 178009.0000 178009.0000 -68.42%
1989 556312.1217 652701.0000 741706.0000 385687.0000 563697.0000 -13.64%
1988 879448.4596 993886.0000 1000000.0000 593365.0000 652701.0000 -33.33%
1987 928643.6827 771374.0000 1000000.0000 623033.0000 979052.0000 26.92%
1986 766856.9283 504360.0000 1000000.0000 504360.0000 771374.0000 52.94%
1985 355944.7100 326351.0000 712038.0000 237346.0000 504360.0000 54.55%
1984 407129.1182 356019.0000 593365.0000 296682.0000 326351.0000 -8.33%
1983 578900.1079 445024.0000 830711.0000 326351.0000 356019.0000 -20.00%
1982 529925.3362 445024.0000 726872.0000 385687.0000 445024.0000 -3.23%
1981 442198.0810 155818.0000 830711.0000 133507.0000 459858.0000 195.13%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.077B $0.018B
Dominari Holdings Inc. primarily focused on the development of a diverse portfolio of small-molecule anticancer and antiviral therapeutics and related patent technology. The Company's fintech and financial services business will be operated through its subsidiary, Dominari Financial Inc. Dominari Holdings Inc., formerly known as AIkido Pharma Inc., is based in NEW YORK.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.830B 32.20
Zoetis (ZTS) United States $72.858B 27.18
Daiichi Sankyo, - (DSNKY) Japan $48.987B 24.92
Takeda Pharmaceutical (TAK) Japan $45.406B 9.03
Sandoz Group AG (SDZNY) Switzerland $21.173B 0.00
Summit Therapeutics (SMMT) United States $18.114B 0.00
Merck (MKKGY) Germany $17.092B 12.52
United Therapeutics (UTHR) United States $13.964B 12.35
Shionogi (SGIOY) Japan $13.347B 13.37
Neurocrine Biosciences (NBIX) United States $12.169B 41.68
IPSEN (IPSEY) France $9.836B 0.00
Orion OYJ (ORINY) Finland $8.979B 24.28
Corcept Therapeutics (CORT) United States $8.083B 65.71
Stevanato Group S.p.A (STVN) Italy $7.365B 45.04
Madrigal Pharmaceuticals (MDGL) United States $6.500B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.528B 0.00
Ionis Pharmaceuticals (IONS) United States $5.486B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.777B 14.53
Soleno Therapeutics (SLNO) United States $3.782B 0.00
Catalyst Pharmaceuticals (CPRX) United States $3.010B 10.55
Crinetics Pharmaceuticals (CRNX) United States $2.937B 0.00
Hypermarcas (HYPMY) Brazil $2.857B 18.79
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.326B 12.58
BioCryst Pharmaceuticals (BCRX) United States $2.162B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $2.125B 0.00
Recursion Pharmaceuticals (RXRX) United States $1.850B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $1.764B 0.00
Guardian Pharmacy Services (GRDN) United States $1.677B 0.00
Indivior (INDV) United States $1.577B 6.69
Evotec AG (EVO) Germany $1.445B 0.00
ARS Pharmaceuticals (SPRY) United States $1.407B 0.00
Dyne Therapeutics (DYN) United States $1.403B 0.00
Ocular Therapeutix (OCUL) United States $1.211B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.121B 22.43
Harrow (HROW) United States $1.030B 0.00
Ardelyx (ARDX) United States $1.000B 0.00
Collegium Pharmaceutical (COLL) United States $0.963B 5.19
Avadel Pharmaceuticals (AVDL) Ireland $0.906B 0.00
Enliven Therapeutics (ELVN) United States $0.853B 0.00
Cronos Group (CRON) Canada $0.806B 0.00
Xeris Biopharma Holdings (XERS) United States $0.794B 0.00
Akebia Therapeutics (AKBA) United States $0.767B 0.00
AleAnna (ANNA) United States $0.669B 0.00
KalVista Pharmaceuticals (KALV) United States $0.609B 0.00
Xencor (XNCR) United States $0.579B 0.00
Bioventus (BVS) United States $0.574B 14.56
USANA Health Sciences (USNA) United States $0.559B 12.16
Regulus Therapeutics (RGLS) United States $0.550B 0.00
Elite Pharmaceuticals (ELTP) United States $0.545B 0.00
Savara (SVRA) United States $0.542B 0.00
Relay Therapeutics (RLAY) United States $0.523B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.492B 0.00
CytoDyn (CYDY) United States $0.485B 0.00
Altimmune (ALT) United States $0.474B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.473B 0.00
Zevra Therapeutics (ZVRA) United States $0.471B 0.00
Siga Technologies (SIGA) United States $0.443B 9.25
Tourmaline Bio (TRML) United States $0.416B 0.00
Organogenesis (ORGO) United States $0.414B 0.00
Verve Therapeutics (VERV) United States $0.411B 0.00
Oruka Therapeutics (ORKA) United States $0.398B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.360B 9.72
Heron Therapeutics (HRTX) United States $0.293B 0.00
Nature's Sunshine Products (NATR) United States $0.269B 24.85
Aquestive Therapeutics (AQST) United States $0.237B 0.00
ProKidney (PROK) United States $0.232B 0.00
MediWound (MDWD) Israel $0.226B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.219B 0.00
Wellgistics Health (WGRX) United States $0.191B 0.00
OmniAb (OABI) United States $0.188B 0.00
Nanobiotix S.A (NBTX) France $0.181B 0.00
Esperion Therapeutics (ESPR) United States $0.180B 0.00
4D Molecular Therapeutics (FDMT) United States $0.178B 0.00
Avita Medical (RCEL) United States $0.177B 0.00
Liminatus Pharma (LIMN) $0.164B 0.00
Procaps Group, S.A (PROCF) Luxembourg $0.164B 0.00
Journey Medical (DERM) United States $0.159B 0.00
Korro Bio (KRRO) United States $0.152B 0.00
Profound Medical (PROF) Canada $0.151B 0.00
Inhibikase Therapeutics (IKT) United States $0.148B 0.00
Aclaris Therapeutics (ACRS) United States $0.146B 0.00
Aldeyra Therapeutics (ALDX) United States $0.141B 0.00
Protara Therapeutics (TARA) United States $0.134B 0.00
Larimar Therapeutics (LRMR) United States $0.132B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.130B 0.00
Nektar Therapeutics (NKTR) United States $0.128B 0.00
Lyell Immunopharma (LYEL) United States $0.125B 0.00
Innate Pharma SA (IPHYF) France $0.122B 0.00
Lexeo Therapeutics (LXEO) United States $0.117B 0.00
VAXART, INC (VXRT) United States $0.116B 0.00
Achieve Life Sciences (ACHV) Canada $0.113B 0.00
Cassava Sciences (SAVA) United States $0.108B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.106B 0.00
Fractyl Health (GUTS) United States $0.103B 0.00
OptiNose (OPTN) United States $0.097B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.093B 0.00
Cardiol Therapeutics (CRDL) Canada $0.093B 0.00
Champions Oncology (CSBR) United States $0.086B 14.09
Galectin Therapeutics (GALT) United States $0.082B 0.00
Arch Biopartners (ACHFF) Canada $0.079B 0.00
Inotiv (NOTV) United States $0.076B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.075B 55.89
Pyxis Oncology (PYXS) United States $0.075B 0.00
ESSA Pharma (EPIX) Canada $0.073B 0.00
Surrozen (SRZN) United States $0.073B 0.00
Unicycive Therapeutics (UNCY) United States $0.072B 0.00
Telomir Pharmaceuticals (TELO) United States $0.068B 0.00
Vivani Medical (VANI) United States $0.068B 0.00
Assertio Holdings (ASRT) United States $0.066B 0.00
Metagenomi (MGX) United States $0.064B 0.00
Nutriband (NTRB) United States $0.062B 0.00
Context Therapeutics (CNTX) United States $0.061B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.056B 0.00
Prelude Therapeutics (PRLD) United States $0.055B 0.00
Century Therapeutics (IPSC) United States $0.052B 0.00
Mural Oncology (MURA) Ireland $0.051B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.049B 0.00
PMV Pharmaceuticals (PMVP) United States $0.048B 0.00
NRx Pharmaceuticals (NRXP) United States $0.048B 0.00
Karyopharm Therapeutics (KPTI) United States $0.045B 0.00
Avalo Therapeutics (AVTX) United States $0.044B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Acrivon Therapeutics (ACRV) United States $0.039B 0.00
Iterum Therapeutics (ITRM) Ireland $0.038B 0.00
FibroGen (FGEN) United States $0.035B 0.00
Rafael Holdings (RFL) United States $0.034B 0.00
SCYNEXIS (SCYX) United States $0.031B 0.00
PolyPid (PYPD) Israel $0.030B 0.00
Tempest Therapeutics (TPST) United States $0.025B 0.00
Enlivex Therapeutics (ENLV) Israel $0.023B 0.00
CASI Pharmaceuticals (CASI) China $0.023B 0.00
Natural Alternatives (NAII) United States $0.020B 0.00
Relmada Therapeutics (RLMD) United States $0.020B 0.00
Lipocine (LPCN) United States $0.019B 0.00
BioVie (BIVI) United States $0.019B 0.00
DURECT (DRRX) United States $0.019B 0.00
Jupiter Neurosciences (JUNS) United States $0.019B 0.00
VYNE Therapeutics (VYNE) United States $0.017B 0.00
TherapeuticsMD (TXMD) United States $0.017B 0.00
Mannatech (MTEX) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Ernexa Therapeutics (ERNA) United States $0.015B 0.00
MEI Pharma (MEIP) United States $0.014B 0.00
ProPhase Labs (PRPH) United States $0.014B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.013B 0.00
Cosmos Health (COSM) United States $0.013B 0.00
Vivos Therapeutics (VVOS) United States $0.013B 0.00
BioLineRx (BLRX) Israel $0.012B 0.00
Scienture Holdings (SCNX) United States $0.012B 0.00
Talphera (TLPH) United States $0.011B 0.00
Minerva Neurosciences (NERV) United States $0.010B 1.68
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Biomerica (BMRA) United States $0.009B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Phio Pharmaceuticals (PHIO) United States $0.009B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Ainos (AIMD) United States $0.008B 0.00
Carisma Therapeutics (CARM) United States $0.008B 0.00
Citius Pharmaceuticals (CTXR) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
Klotho Neurosciences (KLTO) United States $0.007B 0.00
Traws Pharma (TRAW) United States $0.007B 0.00
Lyra Therapeutics (LYRA) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.006B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.006B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.005B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Xenetic Biosciences (XBIO) United States $0.005B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
Conduit Pharmaceuticals (CDT) United States $0.004B 0.00
Alaunos Therapeutics (TCRT) United States $0.004B 0.00
Incannex Healthcare (IXHL) Australia $0.004B 0.00
Jaguar Animal Health (JAGX) United States $0.004B 0.00
PainReform (PRFX) Israel $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
InMed Pharmaceuticals (INM) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
SciSparc (SPRC) Israel $0.003B 0.00
Redhill Biopharma (RDHL) Israel $0.003B 0.00
CERo Therapeutics Holdings (CERO) United States $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
SHINECO (SISI) China $0.001B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.001B 0.00
Petros Pharmaceuticals (PTPI) United States $0.000B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00